Vericel Corp Ord Stock Performance
| VCEL Stock | USD 56.71 0.55 0.96% |
On a scale of 0 to 100, Vericel Corp holds a performance score of 6. The entity has a beta of 1.93, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vericel Corp will likely underperform. Please check Vericel Corp's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Vericel Corp's existing price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.52 | Five Day Return 8.5 | Year To Date Return 65.02 | Ten Year Return 2 K | All Time Return (94.86) |
Last Split Factor 1:20 | Last Split Date 2013-10-16 |
1 | Acquisition by Rubino Alan L of 3200 shares of Vericel Corp subject to Rule 16b-3 | 08/30/2024 |
2 | Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 10.95 subject to Rule 16b-3 | 09/03/2024 |
3 | Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3 | 09/11/2024 |
4 | Disposition of 5834 shares by Gilman Steven C of Vericel Corp at 45.54 subject to Rule 16b-3 | 09/18/2024 |
5 | Acquisition by Jonathan Siegal of 937 shares of Vericel Corp subject to Rule 16b-3 | 09/30/2024 |
6 | Disposition of 568 shares by Jonathan Siegal of Vericel Corp at 41.9 subject to Rule 16b-3 | 10/01/2024 |
7 | Vericel Corp director sells shares worth over 235k | 10/04/2024 |
8 | Acquisition by Gilman Steven C of 5833 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 10/16/2024 |
9 | Strength Seen in Prothena Can Its 15.0 percent Jump Turn into More Strength | 10/29/2024 |
10 | Vericel Corp Q3 2024 Earnings Report Preview What To Look For | 11/06/2024 |
11 | Vericel Corp Q3 2024 Earnings Revenue Hits 57.9M, EPS at -0.02, Surpassing Estimates | 11/07/2024 |
12 | Vericel Earns Buy Rating from HC Wainwright | 11/08/2024 |
13 | Heres Why Momentum in Vericel Should Keep going | 11/11/2024 |
14 | Disposition of 2500 shares by Zerbe Robert L Md of Vericel Corp at 57.5 subject to Rule 16b-3 | 11/12/2024 |
15 | Acquisition by Zerbe Robert L Md of 2500 shares of Vericel Corp at 13.05 subject to Rule 16b-3 | 11/13/2024 |
16 | Acquisition by Sean Flynn of 1474 shares of Vericel Corp at 16.25 subject to Rule 16b-3 | 11/18/2024 |
17 | Vericel Meets 80-Plus Relative Strength Rating Benchmark | 11/20/2024 |
| Begin Period Cash Flow | 51.1 M |
Vericel |
Vericel Corp Relative Risk vs. Return Landscape
If you would invest 4,929 in Vericel Corp Ord on August 23, 2024 and sell it today you would earn a total of 742.00 from holding Vericel Corp Ord or generate 15.05% return on investment over 90 days. Vericel Corp Ord is currently generating 0.265% in daily expected returns and assumes 3.064% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Vericel, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vericel Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vericel Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vericel Corp Ord, and traders can use it to determine the average amount a Vericel Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0865
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VCEL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.06 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Vericel Corp is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vericel Corp by adding it to a well-diversified portfolio.
Vericel Corp Fundamentals Growth
Vericel Stock prices reflect investors' perceptions of the future prospects and financial health of Vericel Corp, and Vericel Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vericel Stock performance.
| Return On Equity | 0.0154 | ||||
| Return On Asset | -0.0022 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 2.82 B | ||||
| Shares Outstanding | 49.36 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 10.98 X | ||||
| Price To Sales | 12.46 X | ||||
| Revenue | 197.52 M | ||||
| Gross Profit | 109.79 M | ||||
| EBITDA | 2.86 M | ||||
| Net Income | (3.18 M) | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 88.14 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 5.23 X | ||||
| Cash Flow From Operations | 35.31 M | ||||
| Earnings Per Share | 0.08 X | ||||
| Market Capitalization | 2.83 B | ||||
| Total Asset | 353.66 M | ||||
| Retained Earnings | (403.18 M) | ||||
| Working Capital | 159.88 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
About Vericel Corp Performance
By examining Vericel Corp's fundamental ratios, stakeholders can obtain critical insights into Vericel Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Vericel Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 77.12 | 73.26 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Vericel Corp Ord performance evaluation
Checking the ongoing alerts about Vericel Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vericel Corp Ord help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vericel Corp Ord had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 197.52 M. Net Loss for the year was (3.18 M) with profit before overhead, payroll, taxes, and interest of 109.79 M. | |
| Vericel Corp Ord has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investors.com: Vericel Meets 80-Plus Relative Strength Rating Benchmark |
- Analyzing Vericel Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vericel Corp's stock is overvalued or undervalued compared to its peers.
- Examining Vericel Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vericel Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vericel Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vericel Corp's stock. These opinions can provide insight into Vericel Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.